Clinical Trial Update: Thymoglobulin in Cadaver Donor [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Thymoglobulin to prevent kidney injury in brain-dead donors has completed. Trial results are not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Prevention of Kidney Injury Associated With Brain Death | Phase 2 | Status: COMPLETED